Yundeok Kim

793 total citations
41 papers, 585 citations indexed

About

Yundeok Kim is a scholar working on Hematology, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, Yundeok Kim has authored 41 papers receiving a total of 585 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Hematology, 11 papers in Pathology and Forensic Medicine and 9 papers in Molecular Biology. Recurrent topics in Yundeok Kim's work include Acute Myeloid Leukemia Research (13 papers), Lymphoma Diagnosis and Treatment (11 papers) and CNS Lymphoma Diagnosis and Treatment (5 papers). Yundeok Kim is often cited by papers focused on Acute Myeloid Leukemia Research (13 papers), Lymphoma Diagnosis and Treatment (11 papers) and CNS Lymphoma Diagnosis and Treatment (5 papers). Yundeok Kim collaborates with scholars based in South Korea and United States. Yundeok Kim's co-authors include Jinkyun Cho, Yoo Hong Min, June‐Won Cheong, Jin Seok Kim, Soo‐Jeong Kim, Ji Eun Jang, Jung Yeon Lee, Yu Ri Kim, Haerim Chung and Junemo Koo and has published in prestigious journals such as Blood, PLoS ONE and Applied Energy.

In The Last Decade

Yundeok Kim

38 papers receiving 575 citations

Peers

Countries citing papers authored by Yundeok Kim

Since Specialization

Citations

This map shows the geographic impact of Yundeok Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yundeok Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yundeok Kim more than expected).

Fields of papers citing papers by Yundeok Kim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yundeok Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yundeok Kim. The network helps show where Yundeok Kim may publish in the future.

Co-authorship network of co-authors of Yundeok Kim

This figure shows the co-authorship network connecting the top 25 collaborators of Yundeok Kim. A scholar is included among the top collaborators of Yundeok Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yundeok Kim. Yundeok Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Efficacy, safety, and health-related quality of life in transplant-ineligible newly diagnosed multiple myeloma patients receiving bortezomib maintenance therapy: a study of the Korean Multiple Myeloma Working Party (KMMWP-174 study) 2025 ·Haematologica ·(unknown), Seung Pil Jung, (unknown), (unknown), Jin Seok Kim, (unknown), Seong Kyu Park, Hyo Jung Kim, Gyeong‐Won Lee, Young Hoon Park, (unknown), Jeong‐Ah Kim, Min Kyoung Kim, Yundeok Kim, Ho‐Jin Shin, Ho Sup Lee, Jihyun Kwon, Chang‐Ki Min	0
2	Survival impact of adherence to tyrosine kinase inhibitor in chronic myeloid leukemia 2021 ·The Korean Journal of Internal Medicine ·Yundeok Kim, Tae‐Hwa Go, (unknown), Jii Bum Lee, Seung Taek Lim, Kwang Yong Shim, Jong In Lee, Jee Hyun Kong	10
3	Upfront autologous hematopoietic stem cell transplantation for high-risk patients with double-expressor diffuse large B cell lymphoma 2020 ·Annals of Hematology ·Yu Ri Kim, Sun Och Yoon, Soo‐Jeong Kim, June‐Won Cheong, Haerim Chung, Jung Yeon Lee, Ji Eun Jang, Yundeok Kim, Woo-Ick Yang, Yoo Hong Min, Jin Seok Kim	5
4	Clinical characteristics and treatment outcomes of isolated myeloid sarcoma without bone marrow involvement: a single-institution experience 2017 ·Blood Research ·Jung Yeon Lee, Haerim Chung, Hyunsoo Cho, Ji Eun Jang, Yundeok Kim, Soo‐Jeong Kim, Jin Seok Kim, Shin Young Hyun, Yoo Hong Min, June‐Won Cheong	16
5	The prognostic role of CD68 and FoxP3 expression in patients with primary central nervous system lymphoma 2017 ·Annals of Hematology ·Hyunsoo Cho, Se Hoon Kim, Soo‐Jeong Kim, Jong Hee Chang, Woo Ick Yang, Chang‐Ok Suh, June‐Won Cheong, Yu Ri Kim, Jung Yeon Lee, Ji Eun Jang, Yundeok Kim, Yoo Hong Min, Jin Seok Kim	14
6	A new prognostic model using absolute lymphocyte count in patients with primary central nervous system lymphoma 2016 ·European Journal of Cancer ·Ji Eun Jang, Yu Ri Kim, Soo‐Jeong Kim, Hyunsoo Cho, Haerim Chung, Jung Yeon Lee, Hyunsung Park, Yundeok Kim, June‐Won Cheong, Yoo Hong Min, Jin Seok Kim	29
7	Induction of cytosine arabinoside-resistant human myeloid leukemia cell death through autophagy regulation by hydroxychloroquine 2015 ·Biomedicine & Pharmacotherapy ·Yundeok Kim, (unknown), Hoi-Kyung Jeung, Ji Eun Jang, Jin Seok Kim, June‐Won Cheong, Young Sam Kim, Yoo Hong Min	26
8	High pre-transplant serum ferritin and busulfan-thiotepa conditioning regimen as risk factors for hepatic sinusoidal obstructive syndrome after autologous stem cell transplantation in patients with malignant lymphoma 2015 ·Leukemia & lymphoma ·(unknown), Soo‐Jeong Kim, June‐Won Cheong, Yundeok Kim, Ji Eun Jang, Jung Yeon Lee, Yoo Hong Min, Woo Ick Yang, Jin Seok Kim	13
9	Inhibition of NHE1 Induced Apoptosis in Cytarabine Resistant Leukemia Cell Lines and Primary Leukemia Cells from AML Patients, Which Showed Increased Intracellular pH and NHE1 Activity 2014 ·Blood ·Shin Young Hyun, (unknown), (unknown), Ji Eun Jang, Yundeok Kim, Yu Ri Kim, June‐Won Cheong, Kwang Yong Shim, Yoo Hong Min	2
10	Serum microRNA-21 as a Potential Biomarker for Response to Hypomethylating Agents in Myelodysplastic Syndromes 2014 ·PLoS ONE ·Yundeok Kim, June‐Won Cheong, (unknown), (unknown), Hoi-Kyung Jeung, Soo‐Jeong Kim, (unknown), Jin Seok Kim, (unknown), Yoo Hong Min	25
11	Monoclonal and polyclonal gammopathy measured by serum free light chain and immunofixation subdivide the clinical outcomes of diffuse large B-cell lymphoma according to molecular classification 2014 ·Annals of Hematology ·Yu Ri Kim, Soo‐Jeong Kim, June‐Won Cheong, Yundeok Kim, Ji Eun Jang, Jung Yeon Lee, Yoo Hong Min, Jaewoo Song, Woo Ick Yang, Jin Seok Kim	12
12	Upfront Autologous Stem Cell Transplantation Overcome the poor Prognosis of Non-Germinal Center Subtype of diffuse Large B-Cell Lymphoma in Patients with Advanced Stage and Elevated Serum Lactate Dehydrogenase 2014 ·Blood ·Yu Ri Kim, (unknown), Soo‐Jeong Kim, June‐Won Cheong, Yundeok Kim, Ji Eun Jang, Jung Yeon Lee, Deok‐Hwan Yang, Hye Won Lee, Hyeon‐Seok Eom, Yoo Hong Min, Jin Seok Kim	1
13	Delta-Neutrophil Index Is a Useful Indicator for Initiation of Peripheral Blood Stem Cell Collection in Chemo-Mobilized Patients 2014 ·Blood ·June‐Won Cheong, Soo‐Jeong Kim, Yundeok Kim, Ji Eun Jang, Hyunsung Park, (unknown), Jin Seok Kim, Yoo Hong Min, Yu Ri Kim	1
14	Autophagy Inhibition Overcomes Resistance to Cytosine Arabinoside in Acute Myeloid Leukemia Cells through Inducing Autophagic Cell Death and Intrinsic Pathway Apoptosis 2014 ·Blood ·Yundeok Kim, (unknown), (unknown), Ji Eun Jang, Jin Seok Kim, June‐Won Cheong, Young Sam Kim, Yoo Hong Min	2
15	Early response to high-dose methotrexate, vincristine, and procarbazine chemotherapy-adapted strategy for primary CNS lymphoma: no consolidation therapy for patients achieving early complete response 2013 ·Annals of Hematology ·Yu Ri Kim, Se Hoon Kim, Jong Hee Chang, Chang‐Ok Suh, Soo‐Jeong Kim, Yundeok Kim, (unknown), Ji Eun Jang, Shin Young Hyun, June‐Won Cheong, Yoo Hong Min, Jin Seok Kim	9
16	Karyotypic change between diagnosis and relapse as a predictor of salvage therapy outcome in AML patients 2013 ·Blood Research ·Yundeok Kim, Ji Eun Jang, Shin Young Hyun, (unknown), Soo‐Jeong Kim, Jin Seok Kim, June‐Won Cheong, Yoo Hong Min	9
17	Aurora A kinase expression is increased in leukemia stem cells, and a selective Aurora A kinase inhibitor enhances Ara-C-induced apoptosis in acute myeloid leukemia stem cells 2012 ·The Korean Journal of Hematology ·Soo‐Jeong Kim, Ji Eun Jang, June‐Won Cheong, (unknown), Hoi-Kyung Jeung, Yundeok Kim, (unknown), Yoo Hong Min	16
18	Clinical significance of B cell-activating factor (BAFF) and a proliferation-inducing ligand (APRIL) in acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation 2011 ·The Korean Journal of Hematology ·Jin Seok Kim, Soo‐Jeong Kim, June‐Won Cheong, Yundeok Kim, (unknown), (unknown), Ji Eun Jang, Shin Young Hyun, Yoo Hong Min	7
19	Circulating Exosomal MicroRNA-21 As a Potential Biomarker That May Predict Response to Azacitidine Treatment in Myelodysplastic Syndromes, 2011 ·Blood ·Yoo Hong Min, (unknown), (unknown), Yundeok Kim, Yeo‐Kyeoung Kim, Yuri Kim, Y. Choi, Jin Seok Kim, (unknown), June‐Won Cheong, Hyeoung Joon Kim	1
20	Primary renal aspergillosis and renal stones in both kidneys associated with hematopoietic stem cell transplant 2010 ·The Korean Journal of Hematology ·Hyunsung Park, Mi‐Jung Lee, Yundeok Kim, Yoo Hong Min, Soo‐Jeong Kim, (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact